The development of a COVID-19 vaccine potentially could take as little as nine months by removing the “dead space” in the development process and manufacturing at risk, the US Food and Drug Administration’s Peter Marks said during an Axios webinar on 4 May.
US government scientists and politicians have suggested a vaccine against the novel coronavirus could be available within 12-18 months, an...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?